<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01502462</url>
  </required_header>
  <id_info>
    <org_study_id>Severe_Isol_TR</org_study_id>
    <nct_id>NCT01502462</nct_id>
  </id_info>
  <brief_title>Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without&#xD;
      significant left-sided valvular or myocardial diseases.&#xD;
&#xD;
      Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria Severe isolated TR for more than 6 months&#xD;
&#xD;
      Exclusion criteria&#xD;
&#xD;
        1. Severe mitral and aortic valvular heart disease&#xD;
&#xD;
        2. Age equals to or more than 75 years&#xD;
&#xD;
        3. Malignancy or serious comorbidity with life expectancy &lt; 5years&#xD;
&#xD;
        4. Acute or subacute infective endocarditis requiring antibiotics therapy&#xD;
&#xD;
        5. Untreated hyperthyroidism&#xD;
&#xD;
        6. Constrictive pericarditis&#xD;
&#xD;
        7. Unclosed significant atrial septal defect&#xD;
&#xD;
        8. Previous tricuspid valve surgery&#xD;
&#xD;
        9. Significant coronary artery disease&#xD;
&#xD;
       10. Cardiomyopathy&#xD;
&#xD;
       11. Pregnancy&#xD;
&#xD;
       12. Severe resting pulmonary hypertension(TR Vmax &gt;4.0 m/s)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all cause death</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalization of cardiovascular causes</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricuspid valve surgery</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">131</enrollment>
  <condition>Tricuspid Regurgitation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without&#xD;
        significant left-sided valvular or myocardial diseases.&#xD;
&#xD;
        Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  Severe isolated TR for more than 6 months&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          1. Severe mitral and aortic valvular heart disease&#xD;
&#xD;
          2. Age equals to or more than 75 years&#xD;
&#xD;
          3. Malignancy or serious comorbidity with life expectancy &lt; 5years&#xD;
&#xD;
          4. Acute or subacute infective endocarditis requiring antibiotics therapy&#xD;
&#xD;
          5. Untreated hyperthyroidism&#xD;
&#xD;
          6. Constrictive pericarditis&#xD;
&#xD;
          7. Unclosed significant atrial septal defect&#xD;
&#xD;
          8. Previous tricuspid valve surgery&#xD;
&#xD;
          9. Significant coronary artery disease&#xD;
&#xD;
         10. Cardiomyopathy&#xD;
&#xD;
         11. Pregnancy&#xD;
&#xD;
         12. Severe resting pulmonary hypertension(TR Vmax &gt;4.0 m/s)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 29, 2011</study_first_submitted>
  <study_first_submitted_qc>December 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2011</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Jong-Min Song</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Clinical course and prognostic factors in patients with severe isolated TR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

